Return to search

OncoMyx Therapeutics rallies $50m Series B

OncoMyx Therapeutics, an immuno-oncology platform company, has raised $50 million in Series B financing.

OncoMyx Therapeutics, an immuno-oncology platform company, has raised $50 million in Series B financing. Lumira Ventures and B Capital Group led the round.

Source: Press Release